Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon purchased 30 shares of the company's stock in a transaction on Wednesday, April 16th. The stock was purchased at an average price of GBX 1,200 ($16.06) per share, for a total transaction of £360 ($481.73).
Liam Condon also recently made the following trade(s):
- On Wednesday, March 19th, Liam Condon purchased 27 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 1,445 ($19.34) per share, for a total transaction of £390.15 ($522.08).
- On Wednesday, January 22nd, Liam Condon bought 30 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 1,362 ($18.23) per share, for a total transaction of £408.60 ($546.77).
Johnson Matthey Price Performance
Shares of Johnson Matthey stock traded up GBX 2 ($0.03) on Monday, hitting GBX 1,202 ($16.08). The company had a trading volume of 351,550 shares, compared to its average volume of 3,281,969. Johnson Matthey PLC has a 52 week low of GBX 1,131 ($15.13) and a 52 week high of GBX 1,917.07 ($25.65). The company has a market cap of £2.01 billion, a PE ratio of 20.43, a PEG ratio of 49,242.50 and a beta of 0.95. The business has a 50-day simple moving average of GBX 1,354.74 and a 200-day simple moving average of GBX 1,403.64. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76.
Johnson Matthey Increases Dividend
The company also recently declared a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. The ex-dividend date was Thursday, April 10th. This is a boost from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. Johnson Matthey's dividend payout ratio (DPR) is 130.84%.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
